Axis-Shield exhibited at the International Society for Intensive Care and Emergency Medicine (ISICEM) conference in Brussels from March 15-18th 2016 where we presented our exciting new sepsis biomarker Heparin Binding Protein.
Please visit our product website www.heparinbindingprotein.com for more details including a presentation that was given at the conference.
Our new sepsis marker HBP is the subject of an important new paper which supports its use in identifying patients who are at risk of developing severe sepsis.
For more information on HBP please visit www.heparinbindingprotein.com
Axis-Shield will attend the annual MEDICA trade fair in Dusseldorf, Germany from 16-19th November 2015. Please visit us in Hall 16 Stand G10 or contact us to arrange a meeting.
Axis-Shield launches new HbA1c immunoassay
Axis-Shield signs a licensing and development deal with Siemens Healthcare for it’s proprietary Active-B12 test